Castle Biosciences reported a gross margin of 77.11% and a net margin of -1.99% for the quarter ended Jun 2026. These financial ratios cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||
| Gross Margin | 80.83% | 81.64% | 77.86% | 77.94% | 76.06% | 75.17% | 75.78% | 77.94% | 81.59% | 81.21% | 80.96% | 83.31% | 81.80% | 81.25% | 81.38% | 79.55% | 77.48% | 78.95% | 75.46% | 77.11% | |||||||||||||
| EBT Margin | -50.23% | -60.53% | -91.20% | -10.35% | -54.71% | -53.63% | -69.44% | -37.42% | -11.18% | -3.84% | -3.41% | 9.06% | 9.65% | 9.14% | -29.86% | -0.17% | -0.46% | -3.12% | -17.22% | -1.63% | |||||||||||||
| EBIT Margin | -50.33% | -60.59% | -91.30% | -11.40% | -58.19% | -59.55% | -74.99% | -42.20% | -15.68% | -8.56% | -7.50% | 5.76% | 5.92% | 4.69% | -31.74% | -4.93% | -8.19% | -4.40% | -22.00% | -2.96% | |||||||||||||
| EBITDA Margin | -50.33% | -60.59% | -91.30% | -11.40% | -58.19% | -59.55% | -74.99% | -42.20% | -15.68% | -8.56% | -7.50% | 5.76% | 5.92% | 4.69% | -31.74% | -4.93% | -8.19% | -4.40% | -22.00% | -2.96% | |||||||||||||
| Operating Margin | -50.33% | -60.59% | -91.30% | -11.40% | -58.19% | -59.55% | -74.99% | -42.20% | -15.68% | -8.56% | -7.50% | 5.76% | 5.92% | 4.69% | -31.74% | -4.93% | -8.19% | -4.40% | -22.00% | -2.96% | |||||||||||||
| Net Margin | -50.23% | -53.44% | -91.70% | -4.73% | -54.71% | -53.78% | -69.47% | -37.45% | -11.23% | -3.90% | -3.47% | 10.25% | 2.65% | 11.11% | -29.38% | 5.29% | -0.60% | -2.68% | -17.35% | -1.99% | |||||||||||||
| FCF Margin | -26.13% | 107.51% | -81.30% | -29.87% | -19.62% | -20.31% | -68.46% | -15.60% | 4.16% | 22.37% | -21.91% | 21.57% | 19.77% | 19.46% | -12.25% | 13.41% | 9.39% | 22.70% | -41.33% | 6.33% | |||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 2.25M | 2.20M | 2.19M | 2.86M | 3.58M | 3.89M | 4.25M | 5.32M | 5.95M | 6.86M | 7.79M | 7.83M | 7.29M | 7.35M | 7.49M | 7.61M | 8.51M | 9.45M | 10.36M | 10.52M | |||||||||||||
| Assets AverageAssets Avg. | 434.61M | 448.13M | 453.50M | 451.40M | 458.10M | 452.57M | 437.11M | 426.15M | 430.71M | 444.68M | 455.92M | 472.91M | 500.94M | 522.90M | 516.48M | 523.22M | 553.76M | 570.67M | 563.18M | 554.49M | |||||||||||||
| Invested CapitalInvested Cap. | 20.85M | 0.41M | 1.11M | 1.94M | 0.42M | 1.67M | 2.92M | ||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.20 | 0.21 | 0.22 | 0.24 | 0.27 | 0.30 | 0.35 | 0.39 | 0.45 | 0.49 | 0.55 | 0.61 | 0.62 | 0.64 | 0.67 | 0.66 | 0.62 | 0.60 | 0.60 | 0.64 | |||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -0.02M | -0.01M | -992.75 | -0.00M | -0.01M | -0.01M | -0.01M | -0.00M | -0.00M | -390.79 | 18.56 | 25.27 | 44.02 | -0.00M | -202.43 | -283.50 | -159.46 | -137.37 | -15.91 | ||||||||||||||
| Debt Ratio | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | ||||||||||||||||||||||
| Times Interest Earned | -0.02M | -0.01M | -992.75 | -0.00M | -0.01M | -0.01M | -0.01M | -0.00M | -0.00M | -390.79 | 18.56 | 25.27 | 44.02 | -0.00M | -202.43 | -283.50 | -159.46 | -137.37 | -15.91 | ||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||
| Enterprise Value | -363.18M | -329.63M | -309.02M | -273.17M | -265.98M | -258.62M | -232.06M | -225.53M | -229.75M | -243.10M | -239.25M | -259.72M | -279.83M | -293.13M | -275.20M | -275.93M | -287.60M | -299.50M | -261.72M | -266.82M | |||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||
| Return on SalesROS | -0.01% | -0.01% | -0.01% | 0.00% | -0.01% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||||||||
| Return on Capital EmployedROCE | -6.76% | -9.47% | -14.57% | -13.09% | -15.30% | -17.49% | -19.62% | -24.73% | -21.59% | -17.12% | -9.89% | -3.64% | -0.23% | 1.83% | -2.88% | -4.88% | -7.01% | -8.53% | -6.47% | -6.45% | |||||||||||||
| Return on Invested CapitalROIC | -0.02% | -0.03% | -0.03% | -0.33% | -0.09% | -0.06% | -0.10% | -0.06% | -0.07% | ||||||||||||||||||||||||
| Return on AssetsROA | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |